O
TRNX

OrbiMed’s TORNIER N V SHARES (NLD) TRNX Stock Holding History

OrbiMed’s Portfolio TRNX Stock Details TRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,805,000
Closed -$120M – 149
2015
Q2 		$120M Hold
4,805,000
– – 1% 30
2015
Q1 		$126M Hold
4,805,000
– – 1.08% 30
2014
Q4 		$123M Hold
4,805,000
– – 1.17% 32
2014
Q3 		$115M Buy
4,805,000
+731,200
+18% +$16.3M 1.2% 33
2014
Q2 		$95.2M Buy
4,073,800
+2,598,700
+176% +$54M 1.12% 33
2014
Q1 		$31.3M Buy
+1,475,100
New +$28.6M 0.38% 50

Other funds holding TRNX

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

OrbiMed's TRNX Position: Q3 2015 in Review

OrbiMed sold out of TORNIER N V SHARES (NLD) (TRNX) in Q3 2015, closing a stake of 4,805,000 shares — an estimated $120M sold.

OrbiMed first reported a position in TRNX in Q1 2014 and held it in 6 quarters. The position peaked at $126M in Q1 2015. 73 funds tracked by Wall St. Rank hold TRNX as of Q3 2015.

  • OrbiMed reported no remaining TORNIER N V SHARES (NLD) position as of Q3 2015 after selling out during the quarter.
  • OrbiMed sold 4,805,000 TORNIER N V SHARES (NLD) shares in Q3 2015, an estimated $120M.
  • OrbiMed first reported a position in TORNIER N V SHARES (NLD) in Q1 2014 and held it in 6 quarters.
  • OrbiMed's TORNIER N V SHARES (NLD) position peaked at $126M in Q1 2015.
  • 73 funds tracked by Wall St. Rank held TORNIER N V SHARES (NLD) as of Q3 2015.

Based on OrbiMed's 13F filing for Q3 2015, filed 13 Nov 2015.